LoginRegister
    Pfizer cancer drug Ibrance higher sales beat Q3 profit estimatesPfizer cancer drug Ibrance higher sales beat Q3 profit estimates
    Amgen Repatha to be available exclusively at 60 pc lower price in 2020Amgen Repatha to be available exclusively at 60 pc lower price in 2020
    Jubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial PersonnelJubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial Personnel
    CDSCO declares 21 drug samples Not of Standard QualityCDSCO declares 21 drug samples Not of Standard Quality
    Biocon bags sixth place in Global Biotech Employers ranking for 2019Biocon bags sixth place in Global Biotech Employers ranking for 2019
    Dr Reddys Srikakulam plant gets 4 USFDA observationsDr Reddys Srikakulam plant gets 4 USFDA observations
    New tuberculosis treatment to be available in India at Rs 73572New tuberculosis treatment to be available in India at Rs 73572
    Macleods Pharma recalls diabetes drug Pioglitazone Hydrochloride tablets in USMacleods Pharma recalls diabetes drug Pioglitazone Hydrochloride tablets in US
    Synthetic stimulant drug Mephedrone worth Rs 3.5 crore seized from Rajdhani Express, 2 heldSynthetic stimulant drug Mephedrone worth Rs 3.5 crore seized from Rajdhani Express, 2 held
    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspectionAlkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection
    Piramal Enterprises plans to raise upto Rs 1000 crore via NCDsPiramal Enterprises plans to raise upto Rs 1000 crore via NCDs
    Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X